Company profile
CTT Pharmaceutical Holdings, Inc.
OTC: CTTH · Healthcare · Medical - Pharmaceuticals
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 43
v0.1 · 5/100 weight · pillars only
↑ return on equity, return on assets · ↓ workforce scale, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
$227.8k
Employees
1
as of 2026-08-25
Market cap
$3.4M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income$227.8k$227.8k2014
Operating income-$672.2k-$672.2k2014
Total assets$1.7M$1.7M2014
Liabilities$1.1M$1.1M2014
Equity$586.6k$586.6k2014
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CTT Pharmaceutical Holdings, Inc.’s financial profile?
CTT Pharmaceutical Holdings, Inc. earned $227.8k in FY2014 net income.
Peers · Healthcare
Revelation Biosciences, Inc.——KMA Holding, Inc.——Cann American Corp.——MetaVia Inc.——Standard Dental Labs Inc.——TransCode Therapeutics, Inc.——Neighbors
Hillsborough →Key facts
CEORyan Khouri
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersTampa, FL
ExchangeOTC: CTTH
Employees1
IPO date1997-04-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.